- ROUNDTABLE: Pharmacy’s future in sync with technology
- Economic analysis: Prescription-only status for PSE would drive up physician visits, healthcare costs
- Walgreens expanding scope of retail pharmacy experience and services heading into fiscal 2014
- CVS Caremark research identifies optimal elements of effective VBID plans
- Pharmaca weathers record Colorado flooding
WASHINGTON — Idaho on Monday became state No. 21 to adopt the real-time, stop-sale technology National Precursor Log Exchange in its battle against the diversion of the cough-cold ingredient pseudoephedrine to methamphetamine.
"Idaho has taken an important step in the battle against methamphetamine by adopting a proven system that provides law enforcement with an invaluable tool to track criminal activity and bring meth dealers and producers to justice," stated Scott Melville, president and CEO of the Consumer Healthcare Products Association. "In addition to aiding police officers, NPLEx allows retailers to block unlawful pseudoephedrine purchases right at the sales counter, and just as importantly, it protects law-abiding consumers' access to the cold and allergy medicines they depend on for relief."
NPLEx is funded by manufacturers who are members of CHPA as the industry solution to combating PSE diversion. NPLEx provides a secure, interconnected electronic logbook that tracks and logs every PSE sale in every store at the precise moment it is happening. When a purchase is made, the logbook advises retailers when to refuse a sale based on an individual's purchase record elsewhere in the state and beyond its borders. The system also provides law enforcement officials with a tool in the fight against meth as the only system that can block the illegal sale in real time and across state lines.
Idaho Gov. "Butch" Otter signed the legislation — Senate Bill 1309 — which originally was introduced by Sen. Joyce Broadsword, R-Dist. 2.